Table 2.
Change from baseline in assessed outcomes at end of the 16-week intervention
| Variables | Intervention group (N = 10) Median, M(SD) | Control group (N = 9) Median, M(SD) | Difference between groups M(SD) |
|---|---|---|---|
| Daily sitting time Hours/day | −0.04,−0.30 (1.90) | 0.18, 0.15 (1.43) | −0.46 (1.70) |
| Breaks in sitting time N/day | 1.00, 1.00 (5.00) | −5.00, −3.00 (9.5) | 5.00 (13.00) |
| Leisure time sitting Hours/day | 0.00, 0.25 (1.72) | −0.50, −1.00 (2.45) | 1.25 (2.01) |
| Physical function | 0.00, −0.05 (0.12) | 0.00, 0.07 (0.28) | −0.12(0.22) |
| Fatigue | |||
| General fatigue | 0.50, 0.40 (3.80) | 1.00, 0.77 (2.54) | −0.38 (3.27) |
| Physical fatigue | −3.50, −0.90 (5.57) | 1.00, 0.44 (3.00) | −1.34 (4.54) |
| Reduced activity | −0.50, −1.80 (4.34) | 1.00, 0.88 (3.72) | −2.70 (4.06) |
| Reduced motivation | 1.50, 1.00 (3.23) | 0.00, 0.00 (2.96) | 1.00 (3.10) |
| Mental fatigue | −1.50, −1.50 (4.43) | 0.00, 0.00 (2.41) | −1.50 (3.62) |
| Pain mm | 4.00, 3.00 (20.52) | 2.00, 7.22 (18.20) | −4.22 (19.45) |
| HR-QoLa | |||
| SF36-PCS | −7.50, −8.38 (5.50) | −20.00, −21.22 (9.47) | 12.85 (7.87) |
| SF36-MCS | 1.50, 4.38 (8.08) | −2.00, −0.55 (7.20) | 4.90 (7.63) |
| Self-efficacy (GSES) | 0.50, 0.70 (2.58) | −1.00, −1.33 (1.87) | 2.03 (2.28) |
| Lipids (mmol/L) | |||
| Cholesterol (total) | −0.45, −0.66 (0.78) | 0.20, 0.24 (0.38) | −0.90 (0.63) |
| HDL | −0.02, −0.046 (0.15) | 0.00, 0.07 (0.36) | −0.12 (0.27) |
| LDL | −0.10, 0.14 (0.89) | 0.10, 0.24 (0.60) | −0.10 (0.77) |
| Triglycerid | −0.36, −0.43 (0.42) | 0.05, 0.12 (0.32) | −0.55 (0.38) |
| HbA1c (mmol/mol)b | 0.05, −0.26 (1.27) | 0.30, 0.36 (0.24) | −0.62 (0.94) |
| Blood pressure (mmHg) | |||
| Systolic | 2.70, 4.71 (6.53) | 1.60, 0.93 (9.37) | 3.77 (8.00) |
| Diastolic | 0.30, −0.27 (5.10) | −2.00, −0.45 (6.70) | 0.19 (5.90) |
| Weight (Kg) | −0.50, 0.20 (2.14) | 0.70, 0.41 (1.10) | −0.21 (1.73) |
| Waist circumference (cm) | 0.00, 8.24 (17.38) | 2.00, 5.00 (8.80) | 3.25 (14.00) |
| BMI | −0.17, 0.07 (0.72) | 0.27, 1.84 (5.03) | −1.78 (3.50) |
| Waist-hip-ratio | −0.01, 0.04 (0.12) | 0.04, 0.04 (0.03) | 0.00 (0.01) |
aTwo participants in the intervention group did not provide answers for the SF-36 questionnaire at end of intervention
bParticipants were not fasting before measurement of HbA1c